Our co-expression analysis has revealed a close association between CTU2 and the expression of these genes involved in chemokines, chemokine receptors, and MHC across different cancers, strongly suggesting that CTU2 could be indispensable for immunotherapy in diverse tumor types. The gene discussed is CTU2; the disease is neoplasm.